Cargando…

Validation of a prostate cancer polygenic risk score

BACKGROUND: Genome‐wide association studies have identified over 100 single‐nucleotide polymorphisms (SNPs) associated with prostate cancer (PrCa), and polygenic risk scores (PRS) based on their combined genotypes have been developed for risk stratification. We aimed to assess the contribution of PR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Black, Mary H., Li, Shuwei, LaDuca, Holly, Lo, Min‐Tzu, Chen, Jefferey, Hoiness, Robert, Gutierrez, Stephanie, Tippin‐Davis, Brigette, Lu, Hsiao‐Mei, Gielzak, Marta, Wiley, Kathleen, Shi, Zhuqing, Wei, Jun, Zheng, Siqun Lilly, Helfand, Brian T., Isaacs, William, Xu, Jianfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590110/ https://www.ncbi.nlm.nih.gov/pubmed/33258481 http://dx.doi.org/10.1002/pros.24058

Ejemplares similares

False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care
por: Tandy-Connor, Stephany, et al.
Publicado: (2018)

Assessing the clinical utility of genetic risk scores for targeted cancer screening
por: Conran, Carly A., et al.
Publicado: (2021)

Diagnosing hereditary cancer predisposition in men with prostate cancer
por: Pritzlaff, Mary, et al.
Publicado: (2020)

Risk assessment of venous thromboembolism in inflammatory bowel disease by inherited risk in a population-based incident cohort
por: Rifkin, Andrew S, et al.
Publicado: (2023)

Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes
por: Hu, Chunling, et al.
Publicado: (2018)

Prevalence of Germline Pathogenic and Likely Pathogenic Variants in Patients With Second Breast Cancers
por: Yao K, Katharine A, et al.
Publicado: (2020)

Comprehensive Paired Tumor/Germline Testing for Lynch Syndrome: Bringing Resolution to the Diagnostic Process
por: Salvador, Monalyn U., et al.
Publicado: (2019)

Polygenic risk score is a predictor of adenomatous polyps at screening colonoscopy
por: Northcutt, Michael J., et al.
Publicado: (2021)

Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank
por: Wei, Jun, et al.
Publicado: (2020)

Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels
por: LaDuca, Holly, et al.
Publicado: (2017)

Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer
por: Yadav, Siddhartha, et al.
Publicado: (2020)

Reliability of Ancestry-specific Prostate Cancer Genetic Risk Score in Four Racial and Ethnic Populations
por: Shi, Zhuqing, et al.
Publicado: (2022)

Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations
por: Horton, Carolyn, et al.
Publicado: (2022)

Single-Nucleotide Polymorphism–Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis
por: Na, Rong, et al.
Publicado: (2019)

Systematic evaluation of cancer‐specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts
por: Shi, Zhuqing, et al.
Publicado: (2019)

A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients
por: LaDuca, Holly, et al.
Publicado: (2019)

Assessing the performance of genetic risk score for stratifying risk of post-sepsis cardiovascular complications
por: McElligott, Brian, et al.
Publicado: (2023)

Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort
por: Mian, Abrar, et al.
Publicado: (2022)

Genetic Susceptibility for Low Testosterone in Men and Its Implications in Biology and Screening: Data from the UK Biobank
por: Fantus, Richard J., et al.
Publicado: (2021)

Association of sickle cell trait with adverse pregnancy outcomes in a population‐based cohort
por: Hulsizer, Joseph, et al.
Publicado: (2023)

Assessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary Cancer
por: Karam, Rachid, et al.
Publicado: (2019)

Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception
por: Bychkovsky, Brittany L., et al.
Publicado: (2023)

Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception
por: Bychkovsky, Brittany L., et al.
Publicado: (2023)

Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer
por: Glaser, Alexander, et al.
Publicado: (2022)

Germline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition
por: Kamihara, Junne, et al.
Publicado: (2022)

catena-Poly[[[aquacopper(II)]-μ-(biphenyl-2,2′-dicarboxylato)-μ-[N,N′-bis(pyridin-4-yl)urea]] 1.25-hydrate]
por: Uzorka, Ben, et al.
Publicado: (2020)

Poly[[μ-1,3-bis(pyridin-3-yl)urea]bis(μ(4)-succinato)dicopper(II)], a ribbon-like coordination polymer
por: Ezenyilimba, Frederick, et al.
Publicado: (2023)

Poly[[aqua[μ(2)-1,3-bis(pyridin-4-yl)urea-κ(2) N (4):N (4′)]bis(μ(3)-5-tert-butylisophthalato-κ(3) O (1):O (1′):O (3))dizinc(II)] trihydrate], a double-strand coordination polymer
por: Jia, Jason, et al.
Publicado: (2023)

Poly[[μ-1,4-bis(pyridin-4-ylmethyl)piperazine]bis[μ(3)-4-(2-carboxylatoethyl)benzoato]dicopper(II)]
por: Jia, Jason, et al.
Publicado: (2023)

Poly[bis[μ(2)-1,3-bis(pyridin-4-yl)urea-κ(2) N (4):N (4′)]bis(μ(2)-5-methylisophthalato-κ(2) O (1):O (3))dizinc(II)], a parallel interpenetrated slab-like coordination polymer with {3.6(4)8}{3(2)6.7(2)8} 4,4-connected binodal topology
por: Jia, Jason, et al.
Publicado: (2023)

Bis(dimethylmalonato-κ(2) O,O′)bis[4-(4-pyridylamino-κN (4))pyridinium]nickel(II) hexahydrate
por: Farnum, Gregory A., et al.
Publicado: (2008)

Poly[di-μ(3)-chlorido-[μ(2)-(3-pyridyl)(4-pyridyl)methanone-κ(2) N:N′]dicopper(I)]
por: Hittle, Jennifer L., et al.
Publicado: (2008)

Poly[4,4′-iminodipyridinium [di-μ(4)-isophthalato-κ(4) O:O′:O′′:O′′-di-μ(3)-isophthalato-κ(3) O:O′:O′′;κ(4) O:O′:O′′,O′′′-trizinc(II)] dihydrate]
por: Braverman, Maxwell A., et al.
Publicado: (2008)

catena-Poly[[[tetraaquacobalt(II)]-μ-4,4′-bipyridine-κ(2) N:N′] bis(perchlorate) 4,4′-bipyridine disolvate dihydrate]
por: Nettleman, Joseph H., et al.
Publicado: (2008)

Poly[4,4′-iminodipyridinium [tetra-μ(3)-oxido-tetraoxido-di-μ(4)-phosphato-κ(4) O:O′:O′′:O′′′-tetravanadium(V)]]
por: Farnum, Gregory A., et al.
Publicado: (2008)

catena-Poly[[[(dimethylmalonato-κ(2) O:O′)(perchlorato-κO)copper(II)]-μ-bis(3-pyridylmethyl)piperazinediium-κ(2) N (1′):N (4′)] perchlorate dihydrate]
por: Farnum, Gregory A., et al.
Publicado: (2008)

4,4′-Iminodipyridinium bis(hydrogen phthalate)
por: Martin, David P., et al.
Publicado: (2008)

catena-Poly[[(triaquacadmium)-μ-1,4-phenylenediacetato-κ(4) O,O′:O′′,O′′′] dihydrate]
por: Uebler, Jacob W., et al.
Publicado: (2011)

μ-1,4-Bis(pyridin-4-ylmethyl)piperazine-κ(2) N:N′-bis[aquabis(3-bromo-5-carboxybenzoato-κO (1))copper(II)]
por: Meyer, Jodi L., et al.
Publicado: (2012)

Poly[[aqua[μ-1,4-bis(3-pyridylmethyl)piperazine-κ(2) N:N′](μ-isophthalato-κ(2) O (1):O (3))copper(II)]
por: Gandolfo, Chaun M., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_05u78t1fnrqoref0goqiart459